Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
24.98
-1.96 (-7.28%)
Jun 12, 2026, 4:00 PM EDT - Market closed

COAG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
1,104--
Enterprise Value
920--
Debt / Equity Ratio
0.010.010.02
Net Debt / Equity Ratio
-1.00-1.00-0.98
Net Debt / EBITDA Ratio
2.642.641.72
Net Debt / FCF Ratio
3.003.001.88
Quick Ratio
17.6217.6213.45
Current Ratio
18.0318.0313.95
Return on Equity (ROE)
-46.99%-46.99%-
Return on Assets (ROA)
-30.11%-30.11%-
Return on Capital Employed (ROCE)
-38.10%-38.10%-56.20%
SEC Filings: 10-K · 10-Q